@article{5355bf6655924a62a0de19a767aee813,
title = "Improvements in Quality of Life: A New Indication for Treating Hepatitis C Virus Infection in Persons with Substance Use Disorders",
author = "Perumalswami, {Ponni V.} and Talal, {Andrew H.}",
note = "Funding Information: Financial support. This work was supported by the Kaleida Health Foundation (Troup Fund) and the Patient-Centered Outcomes Research Institute (award IHS-1507-31640). Potential conflicts of interest. A. T. has received research grants from AbbVie, Merck, Gilead, Intercept, Conatus, and Abbott Laboratories and has been an advisor to AbbVie, Merck, and Abbott Laboratories. P. P. certifies no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.",
year = "2018",
month = mar,
day = "13",
doi = "10.1093/infdis/jix682",
language = "English",
volume = "217",
pages = "1020--1023",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "7",
}